A New Approach for the GLP-1 Medication Cost Challenge Open enrollment is here, and HR teams are staring down a tough reality: Rising drug costs are creating new challenges for HR, especially around GLP-1 medications
The emerging consensus among dental professionals includes several key points: GLP-1 users need more frequent monitoring, salivary health should be assessed at every visit, and cosmetic outcomes should be discussed proactively
This reduction is close to the weight loss achieved with gastric band surgery, considered the most effective approach to reduce weight in patients suffering from type 2 diabetes and obesity (Whyte
Until then, investors will be looking primarily at the stability of the results, the safety profile, and whether the data will be as compelling outside the relatively specific patient population of obesity and knee arthritis
Intra-Islet Somatostatin Regulates Glucagon Release via Type 2 Somatostatin Receptors in Rats
56 These trials demonstrate that although orforglipron is safe and efficacious more longitudinal research is warranted to provide deeper insights into their efficacy, safety and tolerability before their potential incorporation in the pharmacological arsenal against T2DM or obesity
